Strategic funding partnerships validating our biophysics-driven approach to breast cancer risk assessment.
Validated Innovation Path
WAVED’s funding track record demonstrates consistent validation of our interpretable, biophysics-driven technology by leading research institutions and federal agencies. As opposed to opaque AI approaches that struggle to gain clinical trust, our scientifically transparent methodology has attracted support from the National Cancer Institute, the National Science Foundation, and respected accelerator programs – validating both our technical approach and commercial potential.
This funding progression represents more than financial support – it demonstrates rigorous peer review of our technology, business model, and team capabilities. Each award has advanced our path from university research to clinical-ready technology, positioning WAVED for successful commercialization and regulatory approval.
Current Strategic Partnerships
Our active funding partnerships are accelerating clinical translation and commercial readiness:
Maine Center for Entrepreneurs
Programs: Top Gun & BioStartup Accelerator
Focus: Business development, market validation, and investor readiness for our interpretable AI platform in clinical settings.
NIH Technical & Business Assistance
Award: TABA Program Funding
Impact: Accelerating product development and regulatory pathway planning for our mammography enhancement technology.
National Cancer Institute STTR
Achievement: $400K Phase I Completed
Significance: Federal validation of our biophysics-driven approach to breast cancer risk assessment, demonstrating superiority over black box AI methods.
Maine Technology Institute
Partnership: Innovation Economy Support
Value: State-level recognition and funding support for developing Maine’s next breakthrough medical technology.
Foundation Building: Completed Programs
Our comprehensive foundation in entrepreneurship and technology development:
VentureWell E-Team Program
Early-stage innovation support and entrepreneurship training
NSF Innovation Corps (I-Corps)
Customer discovery and market validation for our technology
University of Maine MIRTA
Research commercialization and IP strategy development
Maine Startup Challenge
Business plan competition and entrepreneurial recognition
Greenlight Maine College
Student entrepreneurship competition and early validation
Qualcomm Innovator Stipend
Technology innovation support and development funding
What This Means for Partners & Investors
De-Risked Technology
Federal validation through NCI funding reduces technical and regulatory risk, providing confidence in our biophysics-driven approach over unproven AI methods.
Proven Team Execution
Successful completion of multiple competitive programs demonstrates our ability to execute on milestones and deliver results to stakeholders.
Market-Ready Technology
Progression from research through validation programs positions WAVED for clinical partnerships and commercial deployment.
Strategic Growth Path
Our funding track record establishes credibility for future investment rounds and strategic partnerships in the medical technology sector.
Ready for Strategic Partnerships
Our validated funding track record and proven technology development capabilities position WAVED for strategic partnerships with healthcare systems, medical device companies, and investors seeking interpretable solutions in breast cancer screening.